Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01168973
What this trial is testing

Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 1,253
Not applicableLooking for participantsNCT06816095
What this trial is testing

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

Who this might be right for
Chronic Pelvic Pain Syndrome (CPPS)Radiation-Induced DisorderRadiotherapy Side Effects+2 more
Bernardino Clavo, MD, PhD 40
Post-approval studies (Phase 4)Ended earlyNCT01574131
What this trial is testing

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

Who this might be right for
Second or Third Degree Burns
The University of Texas Medical Branch, Galveston 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815197
What this trial is testing

Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer

Who this might be right for
Penile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma
Latin American Cooperative Oncology Group 37
Large-scale testing (Phase 3)Study completedNCT00295620
What this trial is testing

Secondary Adjuvant Long Term Study With Arimidex

Who this might be right for
Breast Cancer
AstraZeneca 3,484
Testing effectiveness (Phase 2)Ended earlyNCT00392782
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 24
Testing effectiveness (Phase 2)Study completedNCT03669523
What this trial is testing

Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

Who this might be right for
Carcinoma, Non-Small-Cell LungBone Metastases
Centre Hospitalier Annecy Genevois 82
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Post-approval studies (Phase 4)Study completedNCT02052024
What this trial is testing

Myobloc Atrophy Study

Who this might be right for
Spasticity Secondary to Either a Disorder or TraumaSpinal Cord Injury (SCI)Brain Injury+2 more
Georgetown University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015659
What this trial is testing

ZN-c3 + Gemcitabine in Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal Adenocarcinoma
Brandon Huffman, MD 12
Testing effectiveness (Phase 2)Study completedNCT04770623
What this trial is testing

Docetaxel and Irinotecan in Gastric Cancer

Who this might be right for
Stomach CancerGastric CancerChemotherapy Effect
Menoufia University 32
Not applicableUnknownNCT02328391
What this trial is testing

STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE

Who this might be right for
Carcinoma, Squamous Cell
Grupo Gallego de Cancer de Pulmon 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07361991
What this trial is testing

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Who this might be right for
Advan'ce'dAdvanced
The First Affiliated Hospital of Zhengzhou University 50
Testing effectiveness (Phase 2)Study completedNCT01064713
What this trial is testing

Phase II Study of Tesetaxel in Metastatic Melanoma

Who this might be right for
Advanced MelanomaCancer
M.D. Anderson Cancer Center 17
Not applicableUnknownNCT01212796
What this trial is testing

Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

Who this might be right for
Allogeneic Stem Cell Transplantation
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 350
Early research (Phase 1)Not Yet RecruitingNCT06822985
What this trial is testing

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Wan-Guang Zhang 21
Not applicableStudy completedNCT00897078
What this trial is testing

Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings

Who this might be right for
Leukemia
Vanderbilt University 39
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Large-scale testing (Phase 3)Study completedNCT05074589
What this trial is testing

Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Who this might be right for
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
Jiangsu HengRui Medicine Co., Ltd. 298
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780578
What this trial is testing

The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
Fudan University 34
Next Page